Literature DB >> 8009962

Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients.

C Vital1, R Gherardi, A Vital, N Kopp, J F Pellissier, M Soubrier, P Clavelou, R Bellance, M B Delisle, M M Ruchoux.   

Abstract

Mechanisms of peripheral neuropathies in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS) syndrome are poorly understood. A peripheral nerve biopsy was performed in 22 patients. Of these 9 had histological features of Castleman's disease on lymph node biopsies, and 19 had a monoclonal lambda light chain in their serum. Certain nerve fragments were paraffin embedded, others were frozen and studied by direct immunofluorescence, and others were fixed for ultrastructural examination. Paraffin-embedded fragments did not show any amyloid deposits, and at direct immunofluorescence there was no immunoglobulin fixation. At ultrastructural examination, features of uncompacted myelin lamellae (UML) were present in 19 patients, and their frequency varied from 1% to 16% of myelinated fibres. Up to now UML have been reported only in 7 patients with POEMS syndrome in the literature. UML have also been noticed in a few cases of inflammatory demyelinating polyradiculoneuritis and inherited tendency to pressure palsy.

Entities:  

Mesh:

Year:  1994        PMID: 8009962     DOI: 10.1007/BF00296746

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  46 in total

1.  Uncompacted lamellae in three patients with POEMS syndrome.

Authors:  F X Bergouignan; R Massonnat; C Vital; M Barat; P Henry; B Leng; C Effroy
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

2.  Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients.

Authors:  C Brechenmacher; C Vital; C Deminiere; L Laurentjoye; Y Castaing; G Gbikpi-Benissan; J P Cardinaud; J P Favarel-Garrigues
Journal:  Clin Neuropathol       Date:  1987 Jan-Feb       Impact factor: 1.368

3.  The occurrence and significance of myelin with unusually large periodicity.

Authors:  R H King; P K Thomas
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  Polyneuropathy and anasarca: evidence for a new connective-tissue syndrome and vasculopathic contribution.

Authors:  D E Trentham; A T Masi; H W Marker
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

5.  Peripheral neuropathy associated with Castleman's disease.

Authors:  M Donaghy; P Hall; J Gawler; N A Gregson; S Leibowitz; S Jitpimolmard; R H King; P K Thomas
Journal:  J Neurol Sci       Date:  1989-02       Impact factor: 3.181

6.  Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.

Authors:  G D Miralles; J R O'Fallon; N J Talley
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

7.  Interleukin-6 gene expression in Castleman's disease.

Authors:  M B Leger-Ravet; M Peuchmaur; O Devergne; J Audouin; M Raphael; J Van Damme; P Galanaud; J Diebold; D Emilie
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

8.  Uncompacted inner myelin lamellae in inherited tendency to pressure palsy.

Authors:  H Yoshikawa; P J Dyck
Journal:  J Neuropathol Exp Neurol       Date:  1991-09       Impact factor: 3.685

9.  Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy.

Authors:  M Reulecke; M Dumas; C Meier
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

10.  [Chronic polyradiculitis with cutaneous and endocrine signs suggesting a plasmocytic dyscrasia to IgA (author's transl)].

Authors:  M Trillet; C Fischer; S Charhon; B Bady; N Kopp; B Schott
Journal:  Rev Neurol (Paris)       Date:  1980       Impact factor: 2.607

View more
  1 in total

Review 1.  An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.

Authors:  Federica Cerri; Yuri Matteo Falzone; Nilo Riva; Angelo Quattrini
Journal:  J Neurol       Date:  2018-09-27       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.